Other Income/Expenses (Net)

-$10.54M

TTM · Period ending: Jun 30, 2026 · USD

Latest reported-$10.54Mperiod endingJun 30, 2026

LCTX TTM Other Income/Expenses (Net) ($300.00K → -$10.54M)

TTM Other Income/Expenses (Net)

High-resolution chart · PNG

LCTX other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lineage Cell Therapeutics, Inc. Common Stock Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period ending	Other Income/Expenses (Net) (USD)
Jun 30, 2001	0
Mar 31, 2001	0
Dec 31, 2000	0
Sep 30, 2000	0
Jun 30, 2000	2,400,000
Mar 31, 2000	2,400,000
Dec 31, 1999	3,200,000
Sep 30, 1999	3,300,000
Jun 30, 1999	1,000,000
Mar 31, 1999	1,100,000
Sep 30, 1998	400,000
Jun 30, 1998	400,000
Mar 31, 1998	400,000
Dec 31, 1997	800,000
Sep 30, 1997	700,000
Jun 30, 1997	600,000
Mar 31, 1997	2,600,000
Dec 31, 1996	2,000,000
Sep 30, 1996	1,900,000
Jun 30, 1996	1,900,000
Mar 31, 1996	-200,000
Dec 31, 1995	-100,000
Sep 30, 1995	100,000
Jun 30, 1995	200,000
Mar 31, 1995	300,000
Dec 31, 1994	300,000
Sep 30, 1994	200,000
Jun 30, 1994	400,000
Mar 31, 1994	300,000
Dec 31, 1993	500,000
Sep 30, 1993	800,000
Jun 30, 1993	500,000
Mar 31, 1993	500,000
Dec 31, 1992	300,000